Annette Krämer‐Guth
About
In The Last Decade
Annette Krämer‐Guth
20 papers receiving 316 citations
Peers
Comparison fields: 5 of 62
- Surgery 167
- Endocrinology, Diabetes and Metabolism 109
- Nephrology 88
- Cardiology and Cardiovascular Medicine 46
- Transplantation 40
Countries citing papers authored by Annette Krämer‐Guth
This map shows the geographic impact of Annette Krämer‐Guth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Krämer‐Guth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Krämer‐Guth more than expected).
Fields of papers citing papers by Annette Krämer‐Guth
This network shows the impact of papers produced by Annette Krämer‐Guth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Krämer‐Guth. The network helps show where Annette Krämer‐Guth may publish in the future.
Co-authorship network of co-authors of Annette Krämer‐Guth
This figure shows the co-authorship network connecting the top 25 collaborators of Annette Krämer‐Guth. A scholar is included among the top collaborators of Annette Krämer‐Guth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Krämer‐Guth. Annette Krämer‐Guth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 22 | |
| 3 | 53 | |
| 4 | 21 | |
| 5 | 11 | |
| 6 | 12 | |
| 7 | 26 | |
| 8 | 8 | |
| 9 | 14 | |
| 10 | 5 | |
| 11 | 16 | |
| 12 | Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a). | 44 |
| 13 | 19 | |
| 14 | 6 | |
| 15 | Is the determination of LDL cholesterol according to Friedewald accurate in CAPD and HD patients? | 24 |
| 16 | 18 | |
| 17 | Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients. | 2 |
| 18 | Potential role of lipids in the progression of diabetic nephropathy. | 16 |
| 19 | 1 | |
| 20 | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.